Changes in cytokine signaling and extracellular matrix production induced by inflammatory factors in cultured vocal fold fibroblasts

Annals of Otology, Rhinology and Laryngology

Volumn 117, Issue 3, 2008, Pages 227-238

  Lim, Xinhong ^a   Bless, Diane M ^a   Muñoz Del Río, Alejandro ^a   Welham, Nathan V ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b K4/723 CSC ^*  (United States)

Author keywords

Cytokine; Extracellular matrix; Inflammation; Inflammatory factor; Regeneration; Scarless wound healing; Vocal fold fibroblast; Vocal fold scar

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; HYALURONIC ACID; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG POTENTIATION; EXPLANT; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VOCAL CORD; WOUND HEALING;

EID: 40949114246     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940811700311     Document Type: Article

References (46)

1. Benninger MS, Alessi D, Archer S, et al. Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg 1996;115:474-82.
2. Rosen CA, Lee AS, Osborne J, Zullo T, Murry T. Development and validation of the Voice Handicap Index-10. Laryngoscope 2004;114:1549-56.
3. Neuenschwander MC, Sataloff RT, Abaza MM, Hawkshaw MJ, Reiter D, Spiegel JR. Management of vocal fold scar with autologous fat implantation: perceptual results. J Voice 2001;15:295-304.
4. Bjorck G, D'Agata L, Hertegard S. Vibratory capacity and voice outcome in patients with scarred vocal folds treated with collagen injections - case studies. Logoped Phoniatr Vocol 2002;27:4-11.
5. Tucker HM, Wanamaker J, Trott M, Hicks D. Complications of laryngeal framework surgery (phonosurgery). Laryngoscope 1993;103:525-8.
6. Ford CN. Advancements and refinements in phonosurgery. Laryngoscope 1999;109:1891-900.
7. Hirano M, Sato K, Nakashima T. Fibroblasts in human vocal fold mucosa. Acta Otolaryngol 1999;119:271-6.
8. Martin P, D'Souza D, Martin J, et al. Wound healing in the PU.1 null mouse - tissue repair is not dependent on inflammatory cells. Curr Biol 2003;13:1122-8.
9. Szpaderska AM, Zuckerman JD, DiPietro LA. Differential injury responses in oral mucosal and cutaneous wounds. J Dent Res 2003;82:621-6.
10. Chin GS, Stelnicki EJ, Gittes GK, Longaker MT. Characteristics of fetal wound repair. In: Garg HG, Longaker MT, eds. Scarless wound healing. New York, NY: Marcel Dekker, 2000:239-57.
11. Longaker MT, Whitby DJ, Adzick NS, et al. Studies in fetal wound healing, VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. J Pediatr Surg 1990;25:63-9.
12. Lim X, Tateya I, Tateya T, Munoz-Del-Rio A, Bless DM. Immediate inflammatory response and scar formation in wounded vocal folds. Ann Otol Rhinol Laryngol 2006;115:921-9.
13. Wilkinson TS, Potter-Perigo S, Tsoi C, Altman LC, Wight TN. Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. Am J Respir Cell Mol Biol 2004;31:92-9.
14. Granstein RD, Deak MR, Jacques SL, et al. The systematic administration of gamma interferon inhibits collagen synthesis and acute inflammation in a murine skin wounding model. J Invest Dermatol 1989;93:18-27.
15. Yamada Y, Itano N, Hata K, Ueda M, Kimata K. Differential regulation by IL-1β and EGF of expression of three different hyaluronan synthases in oral mucosal epithelial cells and fibroblasts and dermal fibroblasts: quantitative analysis using real-time RT-PCR. J Invest Dermatol 2004;122:631-9.
16. Nakao S, Ogtata Y, Shimizu E, Yamazaki M, Furuyama S, Sugiya H. Tumor necrosis factor α (TNF-α)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFκB in human gingival fibroblasts. Mol Cell Biochem 2002;238:11-8.
17. Luo Y, Kobler JB, Zeitels SM, Langer R. Effects of growth factors on extracellular matrix production by vocal fold fibroblasts in 3-dimensional culture. Tissue Eng 2006;12:3365-74.
18. Broadley C, Gonzalez DA, Nair R, Koriwchak MJ, Ossoff RH, Davidson JM. A tissue-culture model for the study of canine vocal fold fibroblasts. Laryngoscope 1995;105:23-7.
19. Tufvesson E, Westergren-Thorsson G. Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1β and tumor necrosis factor-α. J Cell Biochem 2000;77:298-309.
20. Kolodsick JE, Peters-Golden M, Larios J, Toews GB, Thannickal VJ, Moore BB. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol 2003;29:537-44.
21. R Development Core Team (2005). R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-00-3, URL http://www.R-project.org.
22. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comp Graph Stat 1996;5:299-314.
23. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986;163:1433-50.
24. Sampson PM, Rochester CL, Freundlich B, Elias JA. Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J Clin Invest 1992;90:1492-503.
25. Ohkawa T, Ueki N, Taguchi T, et al. Stimulation of hyaluronan synthesis by tumor necrosis factor-alpha is mediated by the p50/p65 NF-kappa B complex in MRC-5 myofibroblasts. Biochim Biophys Acta 1999;1448:416-24.
26. Kao JJ. The NFκB inhibitor pyrrolidine dithiocarbamate blocks IL-1β induced hyaluronan synthase 1 (HAS1) mRNA transcription, pointing at NFκB dependence of the gene HAS1. Exp Gerontol 2006;41:641-7.
27. Branski RC, Perera P, Verdolini K, Rosen CA, Hebda PA, Agarwal S. Dynamic biomechanical strain inhibits IL-1β-induced inflammation in vocal fold fibroblasts. J Voice 2007;21:651-60.
28. Branski RC, Rosen CA, Verdolini K, Hebda PA. Biochemical markers associated with acute vocal fold wound healing: a rabbit model. J Voice 2005;19:283-9.
29. Branski RC, Rosen CA, Verdolini K, Hebda PA. Markers of wound healing in vocal fold secretions from patients with laryngeal pathology. Ann Otol Rhinol Laryngol 2004;113:23-9.
30. Stuhlmeier KM. Prostaglandin E2: a potent activator of hyaluronan synthase 1 in type-B-synoviocytes. Biochim Biophys Acta 2007;1770:121-9.
31. Wilgus TA, Bergdall VK, Tober KL, et al. The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing. Am J Pathol 2004;165:753-61.
32. Croce MA, Dyne K, Boraldi F, et al. Hyaluronan affects protein and collagen synthesis by in vitro human skin fibroblasts. Tissue Cell 2001;33:326-31.
33. Savani R, Bagli DJ, Harrison RE, Turley EA. The role of hyaluronan-receptor interactions in wound repair. In: Garg HG, Longaker MT, eds. Scarless wound healing. New York, NY: Marcel Dekker, 2000:115-37.
34. Mauviel A, Lapiere JC, Halcin C, Evans CH, Uitto J. Differential cytokine regulation of type I and type VII collagen gene expression in cultured human dermal fibroblasts. J Biol Chem 1994;269:25-8.
35. Chen YQ, Mauviel A, Ryynänen J, Sollberg S, Uitto J. Type VII collagen gene expression by human skin fibroblasts and keratinocytes in culture: influence of donor age and cytokine responses. J Invest Dermatol 1994;102:205-9.
36. Hirano S, Bless DM, Heisey D, Ford CN. Effect of growth factors on hyaluronan production by canine vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2003;112:617-24.
37. Hirano S, Bless DM, Heisey D, Ford C. Roles of hepatocyte growth factor and transforming growth factor 1 in production of extracellular matrix by canine vocal fold fibroblasts. Laryngoscope 2003;113:144-8.
38. Ellis IR, Schor SL. Differential effects of TGF-β1 on hyaluronan synthesis by fetal and adult skin fibroblasts: implications for cell migration and wound healing. Exp Cell Res 1996;228:326-33.
39. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 1986;83:4167-71.
40. Cowin AJ, Holmes TM, Brosnan P, Ferguson MW. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds. Eur J Dermatol 2001;11:424-31.
41. Krummel TM, Michna BA, Thomas BL, et al. Transforming growth factor beta (TGF-beta) induces fibrosis in a fetal wound model. J Pediatr Surg 1988;23:647-52.
42. Lanning DA, Nwomeh BC, Montante SJ, Yager DR, Diegelmann RF, Haynes JH. TGF-β1 alters the healing of cutaneous fetal excisional wounds. J Pediatr Surg 1999;34:695-700.
43. Lin RY, Sullivan KM, Argenta PA, Meuli M, Lorenz HP, Adzick NS. Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair. Ann Surg 1995;222:146-54.
44. Soo C, Beanes SR, Hu FY, et al. Ontogenetic transition in fetal wound transforming growth factor-β regulation correlates with collagen organization. Am J Pathol 2003;163:2459-76.
45. Stelnicki EJ, Bullard KM, Harrison MR, Cass DL, Adzick NS. A new in vivo model for the study of fetal wound healing. Ann Plast Surg 1997;39:374-80.
46. Titze IR, Hitchcock RW, Broadhead K, et al. Design and validation of a bioreactor for engineering vocal fold tissues under combined tensile and vibrational stresses. J Biomech 2004;37:1521-9.